Study guide

12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD)

COPR Primary Care Paramedic PCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The COPR PCP Exam & How to Use This Guide

0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan

2 Chapter 1: Professionalism, Ethics & Legal Framework

1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent

3 Chapter 2: Patient-Centred Communication & Clinical Documentation

2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans

4 Chapter 3: Interprofessional Collaboration & Continuum of Care

3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans

5 Chapter 4: Evidence-Informed Practice & Continuing Competence

4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession

6 Chapter 5: Professional Health, Safety & Operational Resilience

5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice

7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care

6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation

8 Chapter 7: Situational Leadership & Scene Operations

7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems

9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness

8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources

10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs

9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment

11 Chapter 10: Diagnostic Monitoring: ECG & Capnography

10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

12 Chapter 11: Airway Management & Ventilation Therapeutics

11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy

13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care

12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine

14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR

13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation

15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies

14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies

16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation

15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting

17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients

16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities

18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology

17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States

19 Chapter 18: Pharmacology & Safe Medication Administration

18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration

20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement

19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care

21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use

20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD)

Key Takeaways Explain This Topic AI

Acute Decompensated Heart Failure (ADHF) with flash pulmonary edema develops from elevated left ventricular end-diastolic pressure transmitting into pulmonary capillaries, causing alveolar flooding, severe dyspnea, orthopnea, bibasilar crackles, JVD, S3 gallop, and pink frothy sputum.

Cardiogenic shock is characterized by profound cardiac pump failure leading to systemic hypoperfusion (SBP <90 mmHg or MAP <65 mmHg, cool mottled skin, oliguria, altered mentation) with elevated cardiac filling pressures.

Prehospital management of severe ADHF with pulmonary edema centers on non-invasive positive pressure ventilation (CPAP 5–10 cmH2O) to recruit alveoli and reduce afterload, combined with titrated sublingual nitroglycerin, provided SBP exceeds 100 mmHg.

Continuous-flow Left Ventricular Assist Devices (LVAD) create continuous non-pulsatile arterial flow, typically rendering peripheral pulses non-palpable and automated oscillometric blood pressure cuffs ineffective; clinicians must measure Mean Arterial Pressure (MAP) using a Doppler ultrasound probe and manual sphygmomanometer (target 70–90 mmHg).

In unresponsive, non-perfusing LVAD patients (MAP <50 mmHg or ETCO2 <20 mmHg with alarms), current international consensus supports standard manual CPR chest compressions; standard defibrillation and synchronized cardioversion are safe, ensuring pads are positioned at least 2 inches away from the internal pump and external controller.

Last updated: September 2026

  • 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD)
  • Pathophysiology of Heart Failure: Forward vs Backward Failure

Heart failure is a complex clinical syndrome resulting from structural or functional cardiac disorders that impair the ventricle's ability to fill with blood (diastolic dysfunction / Heart Failure with preserved Ejection Fraction [HFpEF]) or eject blood forward (systolic dysfunction / Heart Failure with reduced Ejection Fraction [HFrEF]) (CPCF Appendix A #7). Under the Frank-Starling law, physiological stretching of myocardial fibers enhances contractile force; however, in chronic heart failure, excessive ventricular dilation overstretches sarcomeres beyond their optimal overlap, precipitating contractile collapse.

Left-Sided vs Right-Sided Failure

Left Ventricular Failure: Primary failure of the left ventricle causes backward failure (elevated left ventricular end-diastolic pressure [LVEDP] transmits retrograde into the left atrium and pulmonary venous vasculature, increasing pulmonary capillary hydrostatic pressure) and forward failure (decreased stroke volume and inadequate systemic organ perfusion).

Right Ventricular Failure: Most commonly caused secondary to chronic left-sided failure (pulmonary venous hypertension transmitting into the pulmonary arterial bed, causing RV hypertrophy and dilatation). Primary causes include acute right ventricular infarction, massive pulmonary embolism, and chronic pulmonary disease ( cor pulmonale ). Backward failure elevates systemic venous pressures, manifesting as jugular venous distention (JVD), congestive hepatomegaly, hepatojugular reflux, ascites, and dependent peripheral pitting edema.

Acute Decompensated Heart Failure (ADHF) & Flash Pulmonary Edema

Acute Decompensated Heart Failure (ADHF) occurs when compensatory neurohormonal mechanisms (sympathetic nervous system activation and the renin-angiotensin-aldosterone system [RAAS]) become maladaptive, triggering severe fluid retention, intense peripheral vasoconstriction, and dramatic afterload elevation.

Hemodynamics of Flash Pulmonary Edema

When pulmonary capillary hydrostatic pressure exceeds plasma oncotic pressure (normally ~25 mmHg), fluid transudation overwhelms lymphatic clearance mechanisms, flooding the pulmonary interstitial space and bursting into the alveoli:

Severe Dyspnea & Orthopnea: Patients cannot tolerate lying recumbent because venous return from the lower extremities suddenly shifts into the central circulation, overwhelming left ventricular filling capacity.

Paroxysmal Nocturnal Dyspnea (PND): Awakening gasping for air 1 to 2 hours after retiring, caused by interstitial edema reabsorption while supine.

Auscultation Findings: Coarse bibasilar crackles (rales) that progress upward to the lung apices as fluid accumulation increases; expiratory wheezes ('cardiac asthma') caused by peribronchial interstitial cuffing compressing small airways; an S3 ventricular gallop (auscultated over the cardiac apex during rapid early ventricular filling of a dilated compliant chamber).

Pink Frothy Sputum: Microscopic alveolar capillary rupture under extreme hydrostatic pressure extravasates red blood cells and protein-rich fluid into the airways, whipped into a pink foam by respiratory turbulence.

Cardiogenic Shock: Hemodynamic Collapse & Clinical Presentation

Cardiogenic shock represents the extreme end-stage manifestation of pump failure, characterized by primary cardiac output failure leading to cellular hypoxia in the presence of adequate intravascular volume.

Diagnostic Hemodynamics

Profound Systemic Hypotension: Systolic Blood Pressure (SBP) <90 mmHg or Mean Arterial Pressure (MAP) <65 mmHg , or a >30 mmHg drop from baseline, unresponsive to fluid challenges.

Reduced Cardiac Index: Severely depressed cardiac output (cardiac index <2.2 L/min/m²).

Elevated Ventricular Filling Pressures: Pulmonary Capillary Wedge Pressure (PCWP) >15 to 18 mmHg (distinguishing cardiogenic shock from hypovolemic and distributive shock).

Physical Exam Triad of Cardiogenic Shock

Hypoperfusion (Cold Shock): Pale, mottled, cool, and clammy skin; delayed capillary refill (>3 seconds); weak, thready, or non-palpable peripheral pulses.

Neurocognitive Deterioration: Restlessness, acute confusion, somnolence, and agitation secondary to critically diminished cerebral perfusion.

End-Organ Failure: Marked oliguria (<0.5 mL/kg/h urine output), progressive lactic acidosis, and severe myocardial ischemia.

Warning

The Vasodilator Trap in Cardiogenic Shock: While vasodilators (nitroglycerin) are first-line agents in hypertensive ADHF with pulmonary edema, they are lethal in cardiogenic shock . Administering nitrates or ACE inhibitors to a hypotensive patient with SBP <90 mmHg abolishes compensatory sympathetic vascular tone, inducing total cardiovascular collapse. Cardiogenic shock requires inotropic and vasopressor support (norepinephrine, dobutamine) per advanced paramedic scope.

Prehospital Therapeutics: CPAP Biomechanics & Vasodilator Titration

Prehospital intervention for hypertensive ADHF with severe pulmonary edema focuses on reducing preload, decreasing afterload, and restoring gas exchange:

1. Positioning

Place the patient in an immediate High Fowler's position (sitting completely upright with legs dependent). This mechanically pools blood in the pelvic and lower extremity venous capacitance beds, reducing venous return (preload) to the right heart.

2. Continuous Positive Airway Pressure (CPAP)

CPAP delivered at 5 to 10 cmH2O via an airtight mask is the gold-standard non-invasive respiratory intervention:

Pulmonary Mechanics: CPAP increases functional residual capacity (FRC), splints open fluid-flooded and collapsed alveoli, and physically drives intra-alveolar transudate back across the alveolar-capillary membrane into interstitial lymphatic beds. Work of breathing is dramatically curtailed.

Cardiovascular Biomechanics: The elevated positive intrathoracic pressure reduces right ventricular preload (by decreasing the venous return gradient) and reduces left ventricular afterload (by diminishing left ventricular transmural systolic pressure). This double unloading allows the failing myocardium to eject more efficiently.

3. Nitroglycerin Titration

When SBP is >100 to 140 mmHg , sublingual nitroglycerin (0.4 mg spray or tablet every 3 to 5 minutes) acts as an essential pharmacological agent:

Venodilation (Low Dose): Markedly increases systemic venous capacitance, unloading right ventricular preload and reducing pulmonary capillary hydrostatic pressure.

Arteriolar Dilation (High Dose): Reduces systemic vascular resistance, decreasing left ventricular afterload and improving forward stroke volume.

Continuous-Flow Left Ventricular Assist Devices (LVAD): Engineering & Assessment

A Left Ventricular Assist Device (LVAD) is an implantable mechanical circulatory support pump surgically connected to the heart to manage patients with end-stage heart failure (NYHA Class IV / ACC Stage D) as a 'bridge to transplantation' or 'destination therapy.'

Rotary Continuous-Flow Mechanics

Modern devices (e.g., Abbott HeartMate 3, HeartWare HVAD) utilize continuous-flow centrifugal or axial rotary impellers suspended by magnetic levitation. Blood is drawn directly from the apex of the left ventricle via an inflow cannula and propelled continuously through an outflow cannula into the ascending aorta. Because the impeller operates continuously at thousands of revolutions per minute (e.g., 5,000–9,000 RPM):

Non-Pulsatile Circulation: There is no distinct cardiac systole or diastole generated by the pump. The arterial circulation is continuous and laminar.

Absence of Palpable Pulse: In up to 70% to 80% of LVAD patients, peripheral pulses are completely non-palpable (even though the patient is fully conscious, warm, and talking).

Automated BP Monitors Fail: Standard automated oscillometric NIBP cuffs rely on arterial wall pulse oscillations; they repeatedly display error codes or fail to detect a blood pressure in continuous-flow LVAD patients.

Pulse Oximetry Inefficacy: Standard pulse oximeters require pulsatile capillary beds; they frequently fail to track or display an SpO2 waveform.

The External Hardware Components

Percutaneous Driveline: A specialized cable emerging from the patient's upper abdomen, connecting the internal pump to the external controller.

System Controller: A wearable microprocessor unit that monitors pump speed, electrical power, flow rate, and diagnostic alarms.

Power Sources: Two lithium-ion batteries or an external AC wall power unit connected to the controller via heavy-duty cables.

Hemodynamic Monitoring in LVAD: Doppler Mean Arterial Pressure (MAP)

Because arterial flow is non-pulsatile, clinicians cannot obtain standard systolic and diastolic blood pressure readings. Hemodynamic perfusion in an LVAD patient is assessed exclusively via the Mean Arterial Pressure (MAP) using a manual sphygmomanometer and Doppler ultrasound probe :

Place a manual adult blood pressure cuff on the patient's upper arm.

Apply ultrasound transmission gel over the brachial or radial artery and position an 8-MHz vascular Doppler probe at a 45-degree angle to the vessel until a distinct continuous, whooshing arterial flow signal is heard.

Inflate the manual cuff until the Doppler flow sound completely disappears.

Slowly deflate the cuff at 2 mmHg per second. The precise manometer reading at which the continuous Doppler flow sound first reappears represents the patient's Mean Arterial Pressure (MAP) .

Target MAP Range & Clinical Significance

Target MAP: 70 to 90 mmHg .

Hypertension (MAP >90–95 mmHg): Dramatically elevates LVAD afterload. Excessive afterload slows pump flow, increases turbulent shear stress on blood cells, triggers hemolysis, and substantially increases the risk of hemorrhagic stroke and pump thrombosis.

Hypotension (MAP <65 mmHg): Reflects hypovolemia, sepsis, occult gastrointestinal bleeding (common in LVADs due to acquired von Willebrand syndrome and arteriovenous malformations), or acute right ventricular failure.

LVAD Troubleshooting, Alarms & Cardiac Arrest Resuscitation

When assessing an unstable LVAD patient, paramedics must follow a systematic evaluation pathway: LVAD Emergency Assessment Pathway:

  • 1. Check Consciousness & Perfusion (Warm/pink? Alert?)
  • 2. Auscultate Precordium / Epigastrium (Is the continuous pump 'hum' present?)
  • 3. Inspect System Controller Display (Alarms? Speed? Flow? Power? PI?)
  • 4. Check Driveline (Intact? Disconnected? Trauma?)
  • 5. Check Power Supply (Secure battery cables? Backup batteries available?)
  • 6. Obtain Doppler MAP (Target 70–90 mmHg)
  • 7. Contact Regional VAD Coordinator (Phone number on controller tag)
  • Controller Alarms & Troubleshooting

Beeping Alarm / Flashing Yellow: Advisory alarm (e.g., low battery ~15 minutes remaining). Immediately switch to fully charged backup batteries one at a time.

Continuous Siren / Flashing Red: Critical alarm (e.g., pump stopped, driveline disconnected, critical system fault). Check connections immediately. Firmly reconnect any loose driveline or power cables.

Cardiac Arrest & Resuscitation in LVAD Patients

If an LVAD patient is found unresponsive, apneic, and non-perfusing (Doppler MAP <50 mmHg or ETCO2 <20 mmHg with alarms):

Auscultate for Pump Hum: If no mechanical hum is heard, immediately inspect the driveline and power connections. Often, re-establishing power or securing a loose plug restarts the pump and restores instant perfusion.

Manual Chest Compressions (The Current Consensus): Historically, chest compressions were discouraged due to theoretical risks of dislodging the LVAD inflow cannula. Current international guidelines (AHA and International Society for Heart and Lung Transplantation [ISHLT]) endorse performing standard manual chest compressions if the patient is unresponsive, apneic, and confirmed non-perfusing. The risk of death from untreated circulatory arrest far exceeds the low mechanical risk of cannular disruption.

Electrical Defibrillation & Cardioversion: Completely safe and indicated for shockable rhythms (VF/pVT). Defibrillation does not damage the internal pump rotor. Defibrillation pads must be placed in standard anterior-lateral or anterior-posterior positions, ensuring pads are at least 5 cm (2 inches) away from the internal pump housing and external controller.

Clinical Scenario: Severe ADHF with Flash Pulmonary Edema

A 74-year-old male with a history of anterior myocardial infarction and chronic systolic heart failure presents with sudden severe respiratory distress. The paramedic crew finds him sitting bolt upright at the kitchen table, gasping, diaphoresis drenching his shirt, unable to speak in full sentences, and coughing up pink, frothy sputum.

Primary Assessment: Severe respiratory fatigue, RR 36/min with intercostal retractions, SpO2 76% on ambient air. Auscultation reveals diffuse bubbling crackles bilaterally to the apices and an S3 gallop. Vital signs: BP 196/110 mmHg, HR 122 bpm irregular (atrial fibrillation), clear JVD.

Immediate Positioning & High-Flow Oxygen: The patient is kept strictly upright. High-flow oxygen is provided while setting up the non-invasive ventilation circuit.

CPAP Initiation: CPAP mask applied with PEEP set at 5 cmH2O and titrated to 7.5 cmH2O. Inspired oxygen concentration is adjusted to maintain SpO2 >92%.

Vasodilator Administration: Confirming SBP is well above the 100 mmHg threshold (196 mmHg), the paramedic administers sublingual nitroglycerin 0.4 mg spray. Over the next 15 minutes, two additional 0.4 mg doses are delivered at 5-minute intervals under continuous BP monitoring.

Response to Therapy: Within 10 minutes, the combination of CPAP alveolar recruitment and nitroglycerin preload/afterload reduction breaks the hydrostatic pulmonary crisis. The patient's respiratory rate settles to 22/min, crackles recede to the lung bases, pink sputum ceases, SpO2 rises to 94%, and BP moderates to 148/88 mmHg.

Exam Pitfalls & High-Yield LVAD Pearls

Assuming Cardiac Arrest Due to Lack of Palpable Pulse: Never start CPR on an alert, speaking LVAD patient simply because you cannot feel a radial or carotid pulse. Pulselessness is expected in continuous-flow devices.

Using Automated BP Cuffs on LVAD Patients: Wasting precious scene time trying to obtain an automated NIBP reading is an exam failure; immediately reach for the Doppler probe and manual sphygmomanometer to obtain the MAP.

Ignoring Preload in LVAD Hypotension: An LVAD cannot pump blood that does not reach it. If the right ventricle fails or the patient is severely dehydrated, the LVAD will experience a 'suction event' (inflow cannula collapses against the ventricular septum). Treatment for low LVAD flow with hypotension is gentle IV fluid boluses, not vasopressors.

Delaying Contact with the VAD Coordinator: Every LVAD patient carries an emergency contact card with the 24/7 direct phone line to their hospital VAD coordinator. Paramedics should contact this specialist early for real-time troubleshooting.